Zelda Therapeutics shares gain 60% since listing on medicinal cannabis focus

Zelda is implementing a two-pronged strategy to develop Zelda into a leading medicinal cannabis biotechnology company. This approach provides a ...

read more here
Delivered by @can_nab_is